These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38546212)

  • 1. Unravelling influenza correlates of protection: lessons from human A/H1N1 Challenge.
    Cox RJ; Pathirana R
    mBio; 2024 May; 15(5):e0006424. PubMed ID: 38546212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines.
    Krammer F; Weir JP; Engelhardt O; Katz JM; Cox RJ
    Influenza Other Respir Viruses; 2020 Mar; 14(2):237-243. PubMed ID: 31837101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model.
    Memoli MJ; Shaw PA; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Fargis S; Risos K; Powers JH; Davey RT; Taubenberger JK
    mBio; 2016 Apr; 7(2):e00417-16. PubMed ID: 27094330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response.
    Aljurayyan A; Puksuriwong S; Ahmed M; Sharma R; Krishnan M; Sood S; Davies K; Rajashekar D; Leong S; McNamara PS; Gordon S; Zhang Q
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses.
    Price GE; Soboleski MR; Lo CY; Misplon JA; Quirion MR; Houser KV; Pearce MB; Pappas C; Tumpey TM; Epstein SL
    PLoS One; 2010 Oct; 5(10):e13162. PubMed ID: 20976273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human influenza virus challenge identifies cellular correlates of protection for oral vaccination.
    McIlwain DR; Chen H; Rahil Z; Bidoki NH; Jiang S; Bjornson Z; Kolhatkar NS; Martinez CJ; Gaudillière B; Hedou J; Mukherjee N; Schürch CM; Trejo A; Affrime M; Bock B; Kim K; Liebowitz D; Aghaeepour N; Tucker SN; Nolan GP
    Cell Host Microbe; 2021 Dec; 29(12):1828-1837.e5. PubMed ID: 34784508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.
    Castrucci MR; Facchini M; Di Mario G; Garulli B; Sciaraffia E; Meola M; Fabiani C; De Marco MA; Cordioli P; Siccardi A; Kawaoka Y; Donatelli I
    Influenza Other Respir Viruses; 2014 May; 8(3):367-75. PubMed ID: 24373385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.
    Bragstad K; Martel CJ; Thomsen JS; Jensen KL; Nielsen LP; Aasted B; Fomsgaard A
    Influenza Other Respir Viruses; 2011 Jan; 5(1):13-23. PubMed ID: 21138536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers.
    Bean R; Giurgea LT; Han A; Czajkowski L; Cervantes-Medina A; Gouzoulis M; Mateja A; Hunsberger S; Reed S; Athota R; Baus HA; Kash JC; Park J; Taubenberger JK; Memoli MJ
    mBio; 2024 Feb; 15(2):e0237223. PubMed ID: 38193710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.
    Shim BS; Choi YK; Yun CH; Lee EG; Jeon YS; Park SM; Cheon IS; Joo DH; Cho CH; Song MS; Seo SU; Byun YH; Park HJ; Poo H; Seong BL; Kim JO; Nguyen HH; Stadler K; Kim DW; Hong KJ; Czerkinsky C; Song MK
    PLoS One; 2011; 6(11):e27953. PubMed ID: 22140491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine.
    Jones FR; Gabitzsch ES; Xu Y; Balint JP; Borisevich V; Smith J; Smith J; Peng BH; Walker A; Salazar M; Paessler S
    Vaccine; 2011 Sep; 29(40):7020-6. PubMed ID: 21821082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant.
    Zanvit P; Havlícková M; Tácner J; Novotná O; Jirkovská M; Cechová D; Julák J; Sterzl I; Prokesová L
    Immunol Lett; 2008 Jan; 115(2):144-52. PubMed ID: 18160106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infection.
    Easterbrook JD; Kash JC; Sheng ZM; Qi L; Gao J; Kilbourne ED; Eichelberger MC; Taubenberger JK
    Influenza Other Respir Viruses; 2011 May; 5(3):198-205. PubMed ID: 21477139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized mucosal response to intranasal live attenuated influenza vaccine in adults.
    Barría MI; Garrido JL; Stein C; Scher E; Ge Y; Engel SM; Kraus TA; Banach D; Moran TM
    J Infect Dis; 2013 Jan; 207(1):115-24. PubMed ID: 23087433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.
    Zhao G; Sun S; Du L; Xiao W; Ru Z; Kou Z; Guo Y; Yu H; Jiang S; Lone Y; Zheng BJ; Zhou Y
    Virol J; 2010 Jul; 7():151. PubMed ID: 20624292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
    Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.